These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7683585)

  • 61. Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors.
    Hansen PB; Kjaersgaard E; Johnsen HE; Gram J; Pedersen M; Nikolajsen K; Hansen NE
    Br J Haematol; 1993 Sep; 85(1):50-6. PubMed ID: 7504510
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peripheral blood neutrophils of germ-free rats modified by in vivo granulocyte-colony-stimulating factor and exposure to natural environment.
    Ohkubo T; Tsuda M; Suzuki S; El Borai N; Yamamura M
    Scand J Immunol; 1999 Jan; 49(1):73-7. PubMed ID: 10023860
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of recombinant human granulocyte colony-stimulating factor on efficacy of radiation therapy in tumor-bearing rats.
    Kabaya K; Watanabe M; Kusaka M; Akahori H; Seki M; Fushiki M
    Radiat Res; 1994 Jul; 139(1):92-6. PubMed ID: 7517051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].
    Xu B; Tian F; Yu J; Song Y; Shi J; Zhang B; Zhang Y; Yuan Z; Wu Q; Zhang Q; Nan K; Sun Q; Li W; Hu J; Bi J; Meng C; Dai H; Jiang H; Yue S; Cao B; Sun Y; Wang S; Tong Z; Shen P; Wu G; Tang L; Deng Y; Jia L; Shen K; Zhuang W; Xie X; Wu Y; Chen L
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):23-7. PubMed ID: 26796802
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High dose granulocyte colony-stimulating factor enhances survival and hematopoietic reconstruction in canines irradiated by 2.3 Gy mixed fission neutron and gamma ray.
    Li M; Yu ZY; Xing S; Ou HL; Xiong GL; Xie L; Zhao YF; Han AR; Shan YJ; Liu XL; Zhao ZH; Wang XR; Cong YW; Luo QL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):991-8. PubMed ID: 21867631
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.
    Stewart AG; Cotterill T; Harris T
    Immunology; 1994 May; 82(1):51-6. PubMed ID: 7519173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical observation of the salvage therapy using pegylated recombinant human granulocyte colony stimulating factor for grade IV neutropenia induced by concurrent chemoradiotherapy].
    Wu F; Wang H; Li N; Guo Y; Cheng Y; Liu Q; Yang X; Wan X; Wang J
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):708-12. PubMed ID: 25564064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
    Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [rhG-CSF treatment in cyclic neutropenia. Continuous versus intermittent rhG-CSF treatment in cyclic neutropenia].
    Nielsen H; Hansen PB
    Ugeskr Laeger; 1994 Jan; 156(3):324-5. PubMed ID: 8296427
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
    Lichtman SM; Petroni G; Schilsky RL; Johnson JL; Perri RT; Niedzwiecki D; Sklar J; Barcos M; Peterson BA
    Leuk Lymphoma; 2001; 42(6):1255-64. PubMed ID: 11911406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced anti-Pseudomonas aeruginosa activity of a cephalosporin, cefodizime, in rats whose neutrophils were selectively depleted by a monoclonal antibody.
    Araki A; Sendo F
    Microbiol Immunol; 1996; 40(5):333-8. PubMed ID: 8999285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New cytokine dressings. II. Stimulation of oxidative burst in leucocytes in vitro and reduction of viable bacteria within an infected wound.
    Grzybowski J; Janiak MK; Oldak E; Lasocki K; Wrembel-Wargocka J; Cheda A; Antos-Bielska M; Pojda Z
    Int J Pharm; 1999 Jul; 184(2):179-87. PubMed ID: 10387947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transient effect of granulocyte colony-stimulating factor in allo-immune neonatal neutropenia.
    Girlando P; Zuppa AA; Romagnoli C; Tortorolo G
    Biol Neonate; 2000 Nov; 78(4):277-80. PubMed ID: 11093006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanism of protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on Pseudomonas infection.
    Matsumoto M; Tamura M; Matsubara S; Matsuno T; Ono M; Yokota T
    Microbiol Immunol; 1991; 35(6):461-74. PubMed ID: 1717812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
    Tsuda M; Urakami T; Watanabe S; Shimizu H; Inana I; Kikkawa Y; Kitagawa T
    Acta Paediatr Jpn; 1993 Apr; 35(2):124-6. PubMed ID: 7684881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.